The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/19738
StudyName: Eligibility Cancer, Prostate DRKS00009650 NCT00385827
Date of export from the portal: 02.07.2020
Date of Upload / last change: 24.01.2017
License: Creative Commons BY 4.0

----

Description: 
A Safety and Efficacy Study of Siltuximab (CNTO 328) in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC); ODM derived from: https://clinicaltrials.gov/show/NCT00385827
